Lumos Announces FebriDx CLIA Waiver Application Submission
Filed with ASX · · 3 pages · English
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos Signs Binding Term Sheet for A$5M Loan Facility
- Reinstatement to Quotation
- Lumos Signs Pivotal US FebriDx Agreement
- Suspension from Quotation
- Pause in Trading
Later from Lumos Diagnostics
- FY25 Appendix 4E
- LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
- Lumos secures follow-on PKU contract with Aptatek
- Lumos Secures 100% US Medicare Reimbursement for FebriDx
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics